FDA UNTITLED_LETTER - Precision Equine, LLC - September 22, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This UNTITLED LETTER record concerns Precision Equine, LLC, with an inspection on September 22, 2023, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Precision Equine, LLC
Inspection Date: September 22, 2023
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Shauna M. Doherty (Ms.)

Open in Dashboard

ID · b55cf657-4000-4416-9ca0-b60dbbdd1fe9

Violation Codes10

21 CFR 211.113(b)FD&C Act 501(a)(2)(B)21 CFR 21121 U.S.C. 351(a)(2)(A)21 CFR 211.6721 U.S.C. 360b(a)(5)21 CFR 211.165(a)21 CFR 210FD&C Act 201(v)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.